WHA Pushes Pandemic Agreement's Pathogen Access Annex Amid Global Health Preparedness Calls

Global health leaders convened at the 79th World Health Assembly, wrestling with pivotal decisions that could reshape international responses to future pandemics and health crises. Central to the day's proceedings was the ongoing, intricate negotiation surrounding the Pathogen Access and Benefit Sharing (PABS) Annex, a critical component of the ambitious WHO Pandemic Agreement, signaling both progress and the persistent challenges in forging a truly equitable global health framework.

Quick summary

• The 79th World Health Assembly affirmed the continuation of drafting and negotiation for the Pathogen Access and Benefit Sharing (PABS) Annex under the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement.
• Finalizing the PABS Annex is deemed essential for the broader WHO Pandemic Agreement to be opened for signature, with negotiations set to resume in July 2026.
• Discussions also covered preparedness for public health emergencies, implementation of International Health Regulations (IHR), and the severe health impact of the ongoing conflict in the Middle East, including a specific decision on Lebanon.
• A strategic roundtable marked the 10th anniversary of the WHO Health Emergencies Programme (WHE), reflecting on lessons from COVID-19 and emphasizing the need for proactive adaptation, sustainable financing, and equitable medical countermeasures.

Why it matters

The outcomes of the 79th World Health Assembly bear significant weight for the future of global health security, directly impacting how the world will collectively prevent, prepare for, and respond to future pandemics. The Pathogen Access and Benefit Sharing (PABS) Annex is not merely a bureaucratic detail; it is the linchpin of equitable pandemic response. Without a robust and agreed-upon framework for sharing pathogens and the benefits derived from them (like vaccines and treatments), low-income nations risk being sidelined in future health emergencies, perpetuating the 'vaccine apartheid' witnessed during COVID-19.

Moreover, the Assembly’s discussions on the International Health Regulations (IHR) and the health impacts of conflicts underscore a broader commitment to strengthening health systems beyond just infectious diseases. For citizens globally, these decisions translate into the potential for faster, more coordinated, and fairer access to life-saving resources, as well as improved protection of healthcare in vulnerable regions. The ongoing, complex negotiations highlight the deep-seated tensions between national sovereignty and the collective imperative for global health equity, signaling that the path to a truly 'shared responsibility' remains arduous but critical.

For industries, particularly pharmaceuticals and biotechnology, the PABS Annex will define the landscape for research, development, and distribution of medical countermeasures. Its finalization could either streamline or complicate access to vital biological samples, influencing innovation and market access strategies. The global community is watching to see if the lessons from past crises, particularly the stark inequities of COVID-19, will translate into meaningful, legally binding commitments that safeguard humanity's collective health.

Background

The journey towards a comprehensive global framework for pandemic preparedness was significantly galvanized by the devastating impact of the COVID-19 pandemic, which exposed profound weaknesses in international cooperation, equitable access to resources, and swift emergency response mechanisms. Prior to COVID-19, the International Health Regulations (IHR) of 2005 served as the primary legally binding agreement for global health security, focusing on preventing, protecting against, controlling, and providing a public health response to the international spread of disease.

However, the scale of the COVID-19 crisis prompted a widespread recognition among WHO Member States that the IHR, while crucial, needed to be augmented by a more robust and equitable international instrument. This led to the initiation of negotiations for a new WHO Pandemic Agreement, often referred to as a 'Pandemic Treaty,' with the goal of creating a framework that would ensure greater equity, transparency, and collaboration in future health emergencies.

A central, and often contentious, element of this proposed agreement is the Pathogen Access and Benefit Sharing (PABS) Annex. This annex aims to establish a system where countries that share pathogens (disease-causing agents) with the WHO also receive equitable access to the diagnostics, therapeutics, and vaccines developed from those pathogens. Over the past year, the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement has engaged in extensive and complex negotiations on the PABS Annex, reflecting the diverse interests and priorities of Member States regarding intellectual property, sovereign rights over biological materials, and universal health access. The current World Health Assembly marks another critical juncture in this ongoing, often challenging, diplomatic process, with the PABS Annex's finalization remaining the key hurdle for the broader Agreement's ratification.

WHA Tackles Core Challenges Amidst Global Health Landscape

The 79th World Health Assembly commenced with the Director-General, Dr. Tedros Adhanom Ghebreyesus, presenting his comprehensive report on the World Health Organization's extensive work to Member States. This report set the stage for a broad general discussion centered on the critical theme of “Reshaping global health: a shared responsibility.” The theme itself reflects a growing recognition of the interconnectedness of global health challenges and the necessity for collective action, moving beyond siloed national efforts.

Beyond high-level strategy, the Assembly also took time to acknowledge concrete public health achievements. The Secretariat awarded certificates for outstanding contributions to tobacco control, recognizing specific World No Tobacco Day awardees. Such commendations serve to highlight areas where Member States have demonstrated exemplary progress and provide encouragement for continued efforts in public health interventions, which often battle powerful vested interests.

Pathogen Access and Benefit Sharing: The Linchpin of Pandemic Preparedness

The most significant outcome from the day's proceedings revolved around the Pathogen Access and Benefit Sharing (PABS) Annex, an integral component of the proposed WHO Pandemic Agreement. The World Health Assembly confirmed its decision to continue the intensive drafting and negotiation of this Annex through the Intergovernmental Working Group (IGWG), which operates under the mandate of Article 12 of the broader Agreement.

The fundamental objective of the PABS Annex is to create a robust framework that guarantees a more equitable and effective global response to future pandemics. Its design aims to standardize how pathogens discovered in one country are shared globally for scientific research and vaccine development, while simultaneously ensuring that all nations, particularly those with limited resources, benefit fairly from the resulting medical countermeasures. This principle addresses the stark inequities in access to essential health products that became tragically apparent during the COVID-19 pandemic.

Despite extensive negotiations over the past year, Member States have yet to reach a final consensus on the PABS Annex. The outcome of their latest discussions was presented to the Assembly, with the agreement to submit the finalized Annex for consideration at the Eightieth World Health Assembly in May 2027, or potentially at a dedicated special session in late 2026. This timeline underscores the urgency and the complex nature of the outstanding issues. Crucially, the adoption of the PABS Annex is a non-negotiable prerequisite for the entire WHO Pandemic Agreement to be opened for signature, cementing its role as the make-or-break element. To that end, Member States are scheduled to resume negotiations at the seventh meeting of the IGWG, slated for 6-17 July 2026, immediately following the current World Health Assembly.

Addressing Emergency Readiness and Conflict Zones

In Committee A, delegates delved into the multifaceted challenges of preparing for and responding to public health emergencies. This critical discussion included a detailed review of the implementation report on the International Health Regulations (2005), the existing legally binding framework for international health security. Concurrently, the committee also examined the report from the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme, ensuring accountability and continuous improvement of WHO's emergency response capabilities.

A significant portion of the session was dedicated to the grave health impact of the ongoing conflict in the Middle East. Delegates underscored the critical importance of protecting healthcare facilities and health workers in conflict settings, a principle that is frequently violated in contemporary warfare. The committee took note of a specific report detailing WHO’s extensive work in health emergencies within these volatile regions. Reflecting the urgency of the situation, the committee moved to adopt a draft decision directly addressing the health emergency unfolding in Lebanon, highlighting the Assembly's commitment to tangible, region-specific actions.

Lessons from a Decade of Health Emergencies: A Strategic Roundtable

On the sidelines of the main Assembly, a strategic roundtable convened global leaders to reflect on the profound lessons gleaned from COVID-19 and other recent crises. This event held particular significance as it coincided with the tenth anniversary of the WHO Health Emergencies Programme (WHE), a crucial arm of the organization dedicated to managing global health threats.

Dr. Chikwe Ihekweazu, WHE’s Executive Director, opened the session by emphasizing that the Programme’s evolution has been continuously shaped by insights from a succession of emergencies, with COVID-19 serving as a particularly formative experience. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, characterized the pandemic as the “ultimate stress test,” which starkly exposed vulnerabilities in global preparedness, fundamental inequities in access, and a pervasive erosion of trust in institutions. Yet, he noted, it also paradoxically spurred unprecedented innovation and fostered new avenues for global collaboration.

Adding a crucial historical perspective, Dr. Mike Ryan, former Executive Director of WHE, observed that global health systems have historically adapted reactively, only strengthening after crises such as SARS, Ebola, and COVID-19. He stressed the imperative for a paradigm shift: systems must now evolve proactively to anticipate and mitigate future threats rather than merely respond to them.

Experts at the roundtable reinforced these themes with specific recommendations. Professor Johanna Hanefeld of the Robert Koch Institute advocated for a new era of epidemic intelligence, where cutting-edge analytics and artificial intelligence are seamlessly integrated with robust national health systems and underpin strong public trust. Dr. Daniela Garone of Médecins Sans Frontières highlighted the pressing need for sustainable and flexible financing models, warning that over-reliance on reactive, emergency-driven funding severely impedes effective preparedness. Dr. John-Arne Røttingen of the Wellcome Trust emphasized an “end-to-end approach” to medical countermeasures, ensuring that scientific breakthroughs translate rapidly into equitable access and tangible real-world impact for all populations.

Country perspectives offered compelling examples of these lessons in action. Dr. Mekdes Daba Feyssa, Ethiopia’s Minister of Health, described how the COVID-19 pandemic spurred significant investments in critical infrastructure, including laboratories, oxygen systems, and workforce capacity, thereby strengthening the nation’s ability to respond to subsequent outbreaks. Similarly, Dr. Pierre Somsé, Minister from the Central African Republic, showcased how integrated strategies like the Universal Health and Preparedness Review (UHPR) are harmonizing technical, political, and community efforts to enhance preparedness at the grassroots level. The overarching message from the roundtable was unambiguous: COVID-19 exposed both the devastating costs of global unpreparedness and the immense power of collective action. While strides have been made through the Pandemic Agreement and reforms to the International Health Regulations, finalizing the Pathogen Access and Benefit Sharing (PABS) Annex remains paramount. The challenge ahead is clear: to transform these hard-won lessons into sustained investment and foster stronger, more equitable health systems for the future.

Qnews24h insight

The 79th World Health Assembly’s focus on the Pathogen Access and Benefit Sharing (PABS) Annex underscores a fundamental tension that continues to define global health governance: the delicate balance between national sovereignty and the collective imperative for an equitable, robust pandemic response. While Member States acknowledge the catastrophic inequities exposed by COVID-19, the protracted negotiations over PABS reveal deep-seated disagreements on how to practically implement principles of shared responsibility, particularly when it touches upon intellectual property, technology transfer, and national control over biological resources. The fact that its finalization is a precondition for the entire Pandemic Agreement to proceed signals that PABS is not merely an annex but a litmus test of genuine political will to prevent a repeat of past injustices.

This ongoing struggle for consensus highlights a critical insight: recognizing the lessons from a crisis like COVID-19 is one thing; translating those lessons into binding, actionable commitments that require tangible concessions from all parties is an entirely different, and far more complex, challenge. The call for sustainable and flexible financing, paired with the need for an 'end-to-end' approach to medical countermeasures, further emphasizes that without concrete mechanisms for equitable resource and benefit sharing, the aspirational goals of a 'reshaped global health' risk remaining just that – aspirations. The July 2026 IGWG meeting will therefore be a crucial barometer of whether the global community can truly move from reactive crisis management to proactive, equitable solidarity.

Sources

• Seventy-ninth World Health Assembly – Daily update: 19 May 2026 (who.int)

FAQ

• What is the Pathogen Access and Benefit Sharing (PABS) Annex? The PABS Annex is a crucial component of the proposed WHO Pandemic Agreement. It aims to establish a framework that ensures equitable access to pathogens for research and development, and fair sharing of the benefits (like vaccines, treatments) derived from them, particularly for countries that provide the pathogens.
• Why is the PABS Annex so important for the WHO Pandemic Agreement? The PABS Annex is considered critical because its adoption is a prerequisite for the entire WHO Pandemic Agreement to be opened for signature. It addresses fundamental issues of equity and solidarity, aiming to prevent the 'vaccine apartheid' and unequal access to medical countermeasures seen during past pandemics.
• What were the main discussions at the strategic roundtable held during the WHA? The strategic roundtable, coinciding with the 10th anniversary of the WHO Health Emergencies Programme (WHE), focused on lessons learned from COVID-19 and other crises. Discussions emphasized proactive adaptation to future threats, the need for sustainable and flexible financing, advanced epidemic intelligence (including AI), and ensuring an end-to-end approach for equitable access to medical countermeasures.